Stay updated on SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for the SWIPE phase II trial of maintenance pembrolizumab in metastatic non-small cell lung cancer is displayed, with details on the study plan, participants, outcomes, investigators, and associated documents.
    Difference
    49%
    Check dated 2026-11-08T10:19:53.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label updates from v3.7.2 to v3.8.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T11:25:32.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T11:48:10.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T12:34:06.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T14:19:42.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The SWIPE study page now presents a 403 error page, replacing the previously visible trial details and identifiers with a generic error screen, effectively hiding the study information from the public view.
    Difference
    18%
    Check dated 2026-09-20T20:29:26.000Z thumbnail image

Stay in the know with updates to SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SWIPE: Pembrolizumab Switch in NSCLC Clinical Trial page.